7.04
-0.61(-7.97%)
Currency In USD
| Previous Close | 7.65 |
| Open | 7.52 |
| Day High | 7.64 |
| Day Low | 6.9 |
| 52-Week High | 10 |
| 52-Week Low | 2.54 |
| Volume | 980,566 |
| Average Volume | 706,717 |
| Market Cap | 524.58M |
| PE | -6.4 |
| EPS | -1.1 |
| Moving Average 50 Days | 6.11 |
| Moving Average 200 Days | 4.67 |
| Change | -0.61 |
If you invested $1000 in Corvus Pharmaceuticals, Inc. (CRVS) since IPO date, it would be worth $494.04 as of October 19, 2025 at a share price of $7.04. Whereas If you bought $1000 worth of Corvus Pharmaceuticals, Inc. (CRVS) shares 5 years ago, it would be worth $1,738.27 as of October 19, 2025 at a share price of $7.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025
GlobeNewswire Inc.
Oct 17, 2025 2:00 PM GMT
Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) Interim data shows triplet therapy with ciforadenant, ipilimumab and nivo
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
GlobeNewswire Inc.
Oct 02, 2025 8:01 PM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US Operations at Novo Nordisk A/S an
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
GlobeNewswire Inc.
Jul 31, 2025 8:01 PM GMT
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTSOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the c